Altered oxidative stress/antioxidant status in blood of alcoholic subjects is associated with alcoholic liver disease

Drug and Alcohol Dependence

Volumn 143, Issue 1, 2014, Pages 112-119

  Grasselli, Elena ^a,b   Compalati, Andrea D ^a   Voci, Adriana ^a   Vecchione, Giulia ^a   Ragazzoni, Milena ^a   Gallo, Gabriella ^a   Borro, Paolo ^c   Sumberaz, Alessandro ^c   Testino, Gianni ^c   Vergani, Laura ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Alcohol abuse; Antioxidant enzymes; Blood oxidative stress; Liver steatosis; Metallothionein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 GLOBULIN; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BETA GLOBULIN; BILIRUBIN; CATALASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; GLUCOSE; IRON; METALLOTHIONEIN; METALLOTHIONEIN 1A; METALLOTHIONEIN 1E; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; UPREGULATION; ADOLESCENT; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; COMPLICATION; ECHOGRAPHY; LEUKOCYTE; LIPID PEROXIDATION; MEAN CORPUSCULAR VOLUME; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ALCOHOLISM; ANTIOXIDANTS; CASE-CONTROL STUDIES; ERYTHROCYTE INDICES; FATTY LIVER; HUMANS; LEUKOCYTES; LIPID PEROXIDATION; LIVER DISEASES, ALCOHOLIC; MALE; METALLOTHIONEIN; MIDDLE AGED; OXIDATIVE STRESS; UP-REGULATION; YOUNG ADULT;

EID: 84922409921     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.07.013     Document Type: Article

References (58)

1. Aebi H. Catalase in vitro. Methods in Enzimology 1984, 105:121-126.
2. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med. 2002, 32:110-114.
3. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 2006, 65:278-290.
4. Albano E., Clot P., Morimoto M., Tomasi A., Ingelman-Sundberg M., French S.W. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 1996, 23:155-163.
5. Amit Z., Aragon C.M.G. Catalase activity measured in rats naive to ethanol correlates with later voluntary ethanol-consumption-possible evidence for a biological marker system of ethanol intake. Psychopharmacology 1988, 95:512-515.
6. Chalmers D.M., Rinsler M.G., MacDermot S., Spicer C.C., Levi A.J. Biochemical and haematological indicators of excessive alcohol consumption. Gut 1981, 22:992-996.
7. Cheng N., Du B., Wang Y., Gao H., Cao W., Zheng J., Feng F. Antioxidant properties of jujube honey and its protective effects against chronic alcohol-induced liver damage in mice. Food Funct. 2014, 5:900-908.
8. Cherian M.G., Jayasurya A., Bay B.H. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res. Fundam.: Mol. Mech. Mutagen. 2003, 533:201-209.
9. Das S.K., Dhanya L., Varadhan S., Mukherjee S., Vasudevan D.M. Effects of chronic ethanol consumption in blood: a time dependent study on rat. Indian J. Clin. Biochem. 2009, 24:301-306.
10. Dasarathy S., Dasarathy J., Khiyami A., Joseph R., Lopez R., McCullough A.J. Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study. J. Hepatol. 2009, 51:1061-1067.
11. Davis S.R., Cousins R.J. Metallothionein expression in animals: a physiological perspective on function. J. Nutr. 2000, 130:1085-1088.
12. Deshpande N., Kandi S., Kumar P.V.B., Raman K.V., Muddeshwar M. Effect of alcohol consumption on oxidative stress markers and its role in the pathogenesis and progression of liver cirrhosis. Am. J. Med. Biol. Res. 2013, 1:99-102.
13. Dhanda A.D., Collins P.L., Mccune C.A. Is liver biopsy necessary in the management of alcoholic hepatitis?. World J. Gastroenterol. 2013, 19:7825-7829.
14. Drabkin D.L. The standardization of hemoglobin measurement. Am. J. Med. 1949, 217:710.
15. First M.B., GIbbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 2014, American Psychiatric Press, Inc, Washington, D.C.
16. Grasselli E., Canesi L., Voci A., De Matteis R., Demori I., Fugassa E., Vergani L. Effects of 3,5-diiodo-L-thyronine administration on the liver of high fat diet-fed rats. Exp. Biol. Med. (Maywood) 2008, 233:549-557.
17. Grasselli E., Voci A., Demori I., Canesi L., De Matteis R., Goglia F., Lanni A., Gallo G., Vergani L. 3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver. J. Endocrinol. 2012, 212:149-158.
18. Grasselli E., Voci A., Demori I., De Matteis R., Compalati A.D., Gallo G., Vergani L. Effects of binge ethanol on lipid homeostasis and oxidative stress in a rat model of nonalcoholic fatty liver disease. J. Physiol. Biochem. 2014, 70:341-353.
19. Halliwell B. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). Free Radic. Res. 1999, 31:261-272.
20. Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., Kato T., Takeda N., Okuda J., Ida K., Kawahito Y., Yoshikawa T., Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 2007, 102:2708-2715.
21. Hernaez R., Lazo M., Bonekamp S., Kamel I., Brancati F.L., Guallar E., Clark J.M. Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis. Hepatol. 2011, 54:1082-1090.
22. Ignatowicz E., Wozniak A., Kulza M., Senczuk-Przybylowska M., Cimino F., Piekoszewski W., Chuchracki M., Florek E. Exposure to alcohol and tobacco smoke causes oxidative stress in rats. Pharmacol. Rep. 2013, 65:906-913.
23. Ishii H., Kurose I., Kato S. Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress. J. Gastroenterol. Hepatol. 1997, 12:S272-S282.
24. Kagi J.H.R. Overview of Metallothionein. Methods Enzymol. 1991, 205:613-626.
25. Kawamoto E.M., Munhoz C.D., Glezer I., Bahia V.S., Caramelli P., Nitrini R., Gorjao R., Curic R., Scavone C., Marcourakis T. Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol. Aging 2005, 26:857-864.
26. Kohgo Y., Ohtake T., Ikuta K., Suzuki Y., Torimoto Y., Kato J. Dystegulation of systemic iron metabolism in alcoholic liver diseases. J. Gastroenterol. Hepatol. 2008, 23:S78-S81.
27. Lee S.J., Kim S.Y., Min H. Effects of vitamin C and E supplementation on oxidative stress and liver toxicity in rats fed a low-fat ethanol diet. Nutr. Res. Pract. 2013, 7:109-114.
28. Mates J.M., Perez-Gomez C., De Castro I.N. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32:595-603.
29. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244:6049-6055.
30. Morgan T.R. Management of alcoholic hepatitis. Gastroenterol. Hepatol. (NY) 2007, 3:97-99.
31. Nanji A.A. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004, 34:21-25.
32. Orman E.S., Odena G., Bataller R. Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy. J. Gastroenterol. Hepatol. 2013, 28:77-84.
33. Peterson K. Biomarkers for alcohol use and abuse-a summary. Alcohol Res. Health 2004, 28:30-37.
34. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29.
35. Pratt D.S., Kaplan M.M. Primary care: evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 2000, 342:1266-1271.
36. Santolaria F., Perez-Manzano J.L., Milena A., Gonzalez-Reimers E., Gomez-Rodriguez M.A., Martinez-Riera A., Aleman-Valls M.R., Vega-Prieto M.J. Nutritional assessment in alcoholic patients. Its relationship with alcoholic intake, feeding habits, organic complications and social problems. Drug Alcohol Depend. 2000, 59:295-304.
37. Sato M., Bremner I. Oxygen Free-Radicals and Metallothionein. Free Radic. Biol. Med. 1993, 14:325-337.
38. Selvakumar C., Maheshwari Uma, Suganthi, Archana Oxidant-antioxidant disturbance in men classified as obese according to the preliminary WHO guidelines for Asians. J. Stress Physiol. Biochem. 2012, 8:172-181.
39. Seth D., Haber P.S., Syn W.K., Diehl A.M., Day C.P. Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances. J. Gastroenterol. Hepatol. 2011, 26:1089-1105.
40. Shen Z., Munker S., Wang C., Xu L., Ye H., Chen H., Xu G., Zhang H., Chen L., Yu C., Li Y. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. J. Clin. Lipidol. 2014, 8:273-278.
41. Shinde A., Ganu J., Naik P., Sawant A. Oxidative stress and antioxidative status in patients with alcoholic liver disease. Biomed. Res.-India 2012, 23:105-108.
42. Sies H. Oxidative Stress - from Basic Research to Clinical-Application. Am. J. Med. 1991, 91:S31-S38.
43. Tavill A.S., Qadri A.M. Alcohol and iron. Semin. Liver Dis. 2004, 24:317-325.
44. Testino G. Alcoholic hepatitis. J. Med. Life 2013, 6:161-167.
45. Testino G. Alcoholic diseases in hepato-gastroenterology: a point of view. Hepato-Gastroenterology 2008, 55:371-377.
46. Thirumoorthy N., Sunder A.S., Kumar K.T.M., Kumar M.S., Ganesh G.N.K., Chatterjee M. A review of metallothionein isoforms and their role in pathophysiology. World J. Surg. Oncol. 2011, 9:54-60.
47. Tsukamoto H. Conceptual importance of identifying alcoholic liver disease as a lifestyle disease. J. Gastroenterol. 2007, 42:603-609.
48. Tsukamoto H., Machida K., Dynnyk A., Mkrtchyan H. "Second hit" models of alcoholic liver disease. Semin. Liver Dis. 2009, 29:178-187.
49. van Beek J.H.D.A., de Moor M.H.M., Geels L.M., Sinke M.R.T., de Geus E.J.C., Lubke G.H., Kluft C., Neuteboom J., Vink J.M., Willemsen G., Boomsma D.I. The association of alcohol intake with gamma-glutamyl transferase (GGT) levels: evidence for correlated genetic effects. Drug Alcohol Depend. 2014, 134:99-105.
50. Vasak M., Meloni G. Chemistry and biology of mammalian metallothioneins. J. Biol. Inorg. Chem. 2011, 16:1067-1078.
51. Vergani L. Metallothioneins in aquatic organisms: fish, crustaceans, molluscs and echinoderms. Metal ions in life sciences Vol 5 2009, Society of Chemistry Publishing, Cambridge, UK.
52. Vergani L., Grattarola M., Borghi C., Dondero F., Viarengo A. Fish and molluscan metallothioneins-A structural and functional comparison. Febs J. 2005, 272:6014-6023.
53. Vergani L., Lanza C., Rivaro M.L., Abelmoschi G., Shyti G., Veneselli E., Minniti G., Grasselli E., Canesi L., Voci A. Metals, metallothioneins and oxidative stress in blood of autistic children. Res. Autism Spectr. Disord. 2011, 5:286-293.
54. Vidali M., Hietala J., Occhino G., Ivaldi A., Sutti S., Niemela O., Albano E. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers. Free Radic. Biol. Med. 2008, 45:306-311.
55. Whitfield J.B. Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 2001, 38:263-355.
56. Wu D.F., Cederbaum A.I. Oxidative stress and alcoholic liver disease. Semin. Liver Dis. 2009, 29:141-154.
57. Zhou Z.X., Sun X.H., Lambert J.C., Saari J.T., Kang Y.J. Metallothionein-independent zinc protection from alcoholic liver injury. Am. J. Pathol. 2002, 160:2267-2274.
58. Zhou Z.X., Wang L.P., Song Z.Y., Saari J.T., McClain C.J., Kang Y.J. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol. 2005, 166:1681-1690.